Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins-Reference-Cited by-同舟云学术

Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins

Published:2021-12-20 Issue:3 Volume:44 Page:606-614
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Fenlon Jordan B.¹^ORCID,Hutten Ryan J.¹,Weil Christopher R.¹,Lloyd Shane¹,Cannon Donald M.¹,Kerrigan Kathleen²,Cannon Richard B.³,Hitchcock Ying J.¹^ORCID

Affiliation:

1. Department of Radiation Oncology Huntsman Cancer Institute, University of Utah Health Salt Lake City Utah USA

2. Division of Medical Oncology Huntsman Cancer Institute, University of Utah Health Salt Lake City Utah USA

3. Division of Otolaryngology – Head and Neck Surgery School of Medicine, University of Utah Salt Lake City Utah USA

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.26951

Reference31 articles.

1. Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

2. Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

3. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma

4. Appraisal of the AJCC 8th edition pathologic staging modifications for HPV−positive oropharyngeal cancer, a study of the National Cancer Data Base

5. Extracapsular extension is associated with worse distant control and progression-free survival in patients with lymph node-positive human papillomavirus-related oropharyngeal carcinoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck;Japanese Journal of Clinical Oncology;2024-03-07